---
:id: aHR0cDovL3d3dy5zLWN1YmVkLmRrL0FFX0RvbWFpbi9WMSNTUEQ=
:uri: http://www.s-cubed.dk/AE_Domain/V1#SPD
:rdf_type: http://www.assero.co.uk/Tabulation#SdtmSponsorDomain
:label: Sponsor Adverse Events
:has_state:
  :id: aHR0cDovL3d3dy5zLWN1YmVkLmRrL0FFX0RvbWFpbi9WMSNTUERfUlM=
  :uri: http://www.s-cubed.dk/AE_Domain/V1#SPD_RS
  :rdf_type: http://www.assero.co.uk/ISO11179Registration#RegistrationState
  :registration_status: Incomplete
  :administrative_note: ''
  :effective_date: '2016-01-01T00:00:00+00:00'
  :until_date: '2016-01-01T00:00:00+00:00'
  :unresolved_issue: ''
  :administrative_status: ''
  :previous_state: Incomplete
  :multiple_edit: false
  :by_authority:
    :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvUkEjRFVOUzEyMzQ1Njc4OQ==
    :uri: http://www.assero.co.uk/RA#DUNS123456789
    :rdf_type: http://www.assero.co.uk/ISO11179Registration#RegistrationAuthority
    :organization_identifier: '123456789'
    :international_code_designator: DUNS
    :owner: true
    :ra_namespace:
      :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvTlMjU0NVQkVE
      :uri: http://www.assero.co.uk/NS#SCUBED
      :rdf_type: http://www.assero.co.uk/ISO11179Identification#Namespace
      :short_name: S-cubed
      :name: S-cubed Aps
      :authority: www.s-cubed.dk
:has_identifier:
  :id: aHR0cDovL3d3dy5zLWN1YmVkLmRrL0FFX0RvbWFpbi9WMSNTUERfU0k=
  :uri: http://www.s-cubed.dk/AE_Domain/V1#SPD_SI
  :rdf_type: http://www.assero.co.uk/ISO11179Identification#ScopedIdentifier
  :identifier: AE Domain
  :version_label: ''
  :version: 1
  :semantic_version: 0.1.0
  :has_scope:
    :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvTlMjU0NVQkVE
    :uri: http://www.assero.co.uk/NS#SCUBED
    :rdf_type: http://www.assero.co.uk/ISO11179Identification#Namespace
    :short_name: S-cubed
    :name: S-cubed Aps
    :authority: www.s-cubed.dk
:has_previous_version: 
:origin: ''
:change_description: ''
:creation_date: '2016-01-01T00:00:00+00:00'
:last_change_date: '2020-12-02T21:17:13+01:00'
:explanatory_comment: ''
:rule: ''
:ordinal: 1
:includes_column:
- :id: aHR0cDovL3d3dy5zLWN1YmVkLmRrL0FFX0RvbWFpbi9WMSNTUERfU1RVRFlJRA==
  :uri: http://www.s-cubed.dk/AE_Domain/V1#SPD_STUDYID
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmSponsorDomainVariable
  :label: Study Identifier
  :rule: ''
  :ordinal: 1
  :name: STUDYID
  :description: Unique identifier for a study.
  :format: ''
  :ct_and_format: ''
  :compliance: http://www.assero.co.uk/CSN#52070084-cdd3-4ba8-8377-f670e4b0276c
  :ct_reference: []
  :based_on_class_variable: 
  :is_a: 
  :comment: ''
  :used: true
  :notes: ''
  :typed_as: 
  :based_on_ig_variable: http://www.cdisc.org/SDTM_IG_AE/V1#IGD_STUDYID
- :id: aHR0cDovL3d3dy5zLWN1YmVkLmRrL0FFX0RvbWFpbi9WMSNTUERfRE9NQUlO
  :uri: http://www.s-cubed.dk/AE_Domain/V1#SPD_DOMAIN
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmSponsorDomainVariable
  :label: Domain Abbreviation
  :rule: ''
  :ordinal: 2
  :name: DOMAIN
  :description: Two-character abbreviation for the domain.
  :format: ''
  :ct_and_format: ''
  :compliance: http://www.assero.co.uk/CSN#52070084-cdd3-4ba8-8377-f670e4b0276c
  :ct_reference: []
  :based_on_class_variable: 
  :is_a: 
  :comment: ''
  :used: true
  :notes: ''
  :typed_as: 
  :based_on_ig_variable: http://www.cdisc.org/SDTM_IG_AE/V1#IGD_DOMAIN
- :id: aHR0cDovL3d3dy5zLWN1YmVkLmRrL0FFX0RvbWFpbi9WMSNTUERfVVNVQkpJRA==
  :uri: http://www.s-cubed.dk/AE_Domain/V1#SPD_USUBJID
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmSponsorDomainVariable
  :label: Unique Subject Identifier
  :rule: ''
  :ordinal: 3
  :name: USUBJID
  :description: Identifier used to uniquely identify a subject across all studies
    for all applications or submissions involving the product.
  :format: ''
  :ct_and_format: ''
  :compliance: http://www.assero.co.uk/CSN#52070084-cdd3-4ba8-8377-f670e4b0276c
  :ct_reference: []
  :based_on_class_variable: 
  :is_a: 
  :comment: ''
  :used: true
  :notes: ''
  :typed_as: 
  :based_on_ig_variable: http://www.cdisc.org/SDTM_IG_AE/V1#IGD_USUBJID
- :id: aHR0cDovL3d3dy5zLWN1YmVkLmRrL0FFX0RvbWFpbi9WMSNTUERfQUVTRVE=
  :uri: http://www.s-cubed.dk/AE_Domain/V1#SPD_AESEQ
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmSponsorDomainVariable
  :label: Sequence Number
  :rule: ''
  :ordinal: 4
  :name: AESEQ
  :description: Sequence Number given to ensure uniqueness of subject records within
    a domain. May be any valid number.
  :format: ''
  :ct_and_format: ''
  :compliance: http://www.assero.co.uk/CSN#52070084-cdd3-4ba8-8377-f670e4b0276c
  :ct_reference: []
  :based_on_class_variable: 
  :is_a: 
  :comment: ''
  :used: true
  :notes: ''
  :typed_as: 
  :based_on_ig_variable: http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AESEQ
- :id: aHR0cDovL3d3dy5zLWN1YmVkLmRrL0FFX0RvbWFpbi9WMSNTUERfQUVHUlBJRA==
  :uri: http://www.s-cubed.dk/AE_Domain/V1#SPD_AEGRPID
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmSponsorDomainVariable
  :label: Group ID
  :rule: ''
  :ordinal: 5
  :name: AEGRPID
  :description: Used to tie together a block of related records in a single domain
    for a subject.
  :format: ''
  :ct_and_format: ''
  :compliance: http://www.assero.co.uk/CSN#f7d9d4e1-a00a-487e-89db-ebece910ba0d
  :ct_reference: []
  :based_on_class_variable: 
  :is_a: 
  :comment: ''
  :used: true
  :notes: ''
  :typed_as: 
  :based_on_ig_variable: http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AEGRPID
- :id: aHR0cDovL3d3dy5zLWN1YmVkLmRrL0FFX0RvbWFpbi9WMSNTUERfQUVSRUZJRA==
  :uri: http://www.s-cubed.dk/AE_Domain/V1#SPD_AEREFID
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmSponsorDomainVariable
  :label: Reference ID
  :rule: ''
  :ordinal: 6
  :name: AEREFID
  :description: Internal or external identifier such as a serial number on an SAE
    reporting form
  :format: ''
  :ct_and_format: ''
  :compliance: http://www.assero.co.uk/CSN#f7d9d4e1-a00a-487e-89db-ebece910ba0d
  :ct_reference: []
  :based_on_class_variable: 
  :is_a: 
  :comment: ''
  :used: true
  :notes: ''
  :typed_as: 
  :based_on_ig_variable: http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AEREFID
- :id: aHR0cDovL3d3dy5zLWN1YmVkLmRrL0FFX0RvbWFpbi9WMSNTUERfQUVTUElE
  :uri: http://www.s-cubed.dk/AE_Domain/V1#SPD_AESPID
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmSponsorDomainVariable
  :label: Sponsor-Defined Identifier
  :rule: ''
  :ordinal: 7
  :name: AESPID
  :description: 'Sponsor-defined identifier. It may be pre-printed on the CRF as an
    explicit line identifier or defined in the sponsor''s operational database. Example:
    Line number on an Adverse Events page.'
  :format: ''
  :ct_and_format: ''
  :compliance: http://www.assero.co.uk/CSN#f7d9d4e1-a00a-487e-89db-ebece910ba0d
  :ct_reference: []
  :based_on_class_variable: 
  :is_a: 
  :comment: ''
  :used: true
  :notes: ''
  :typed_as: 
  :based_on_ig_variable: http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AESPID
- :id: aHR0cDovL3d3dy5zLWN1YmVkLmRrL0FFX0RvbWFpbi9WMSNTUERfQUVURVJN
  :uri: http://www.s-cubed.dk/AE_Domain/V1#SPD_AETERM
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmSponsorDomainVariable
  :label: Reported Term for the Adverse Event
  :rule: ''
  :ordinal: 8
  :name: AETERM
  :description: Verbatim name of the event.
  :format: ''
  :ct_and_format: ''
  :compliance: http://www.assero.co.uk/CSN#52070084-cdd3-4ba8-8377-f670e4b0276c
  :ct_reference: []
  :based_on_class_variable: 
  :is_a: 
  :comment: ''
  :used: true
  :notes: ''
  :typed_as: 
  :based_on_ig_variable: http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AETERM
- :id: aHR0cDovL3d3dy5zLWN1YmVkLmRrL0FFX0RvbWFpbi9WMSNTUERfQUVNT0RJRlk=
  :uri: http://www.s-cubed.dk/AE_Domain/V1#SPD_AEMODIFY
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmSponsorDomainVariable
  :label: Modified Reported Term
  :rule: ''
  :ordinal: 9
  :name: AEMODIFY
  :description: If AETERM is modified to facilitate coding, then AEMODIFY will contain
    the modified text.
  :format: ''
  :ct_and_format: ''
  :compliance: http://www.assero.co.uk/CSN#f7d9d4e1-a00a-487e-89db-ebece910ba0d
  :ct_reference: []
  :based_on_class_variable: 
  :is_a: 
  :comment: ''
  :used: true
  :notes: ''
  :typed_as: 
  :based_on_ig_variable: http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AEMODIFY
- :id: aHR0cDovL3d3dy5zLWN1YmVkLmRrL0FFX0RvbWFpbi9WMSNTUERfQUVERUNPRA==
  :uri: http://www.s-cubed.dk/AE_Domain/V1#SPD_AEDECOD
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmSponsorDomainVariable
  :label: Dictionary-Derived Term
  :rule: ''
  :ordinal: 10
  :name: AEDECOD
  :description: Dictionary-derived text description of AETERM or AEMODIFY. Equivalent
    to the Preferred Term (PT in MedDRA). The sponsor is expected to provide the dictionary
    name and version used to map the terms utilizing the define.xml external codelist
    attributes
  :format: ''
  :ct_and_format: ''
  :compliance: http://www.assero.co.uk/CSN#52070084-cdd3-4ba8-8377-f670e4b0276c
  :ct_reference: []
  :based_on_class_variable: 
  :is_a: 
  :comment: ''
  :used: true
  :notes: ''
  :typed_as: 
  :based_on_ig_variable: http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AEDECOD
- :id: aHR0cDovL3d3dy5zLWN1YmVkLmRrL0FFX0RvbWFpbi9WMSNTUERfQUVDQVQ=
  :uri: http://www.s-cubed.dk/AE_Domain/V1#SPD_AECAT
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmSponsorDomainVariable
  :label: Category for Adverse Event
  :rule: ''
  :ordinal: 11
  :name: AECAT
  :description: 'Used to define a category of related records. Example: BLEEDING,
    NEUROPSYCHIATRIC.'
  :format: ''
  :ct_and_format: ''
  :compliance: http://www.assero.co.uk/CSN#f7d9d4e1-a00a-487e-89db-ebece910ba0d
  :ct_reference: []
  :based_on_class_variable: 
  :is_a: 
  :comment: ''
  :used: true
  :notes: ''
  :typed_as: 
  :based_on_ig_variable: http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AECAT
- :id: aHR0cDovL3d3dy5zLWN1YmVkLmRrL0FFX0RvbWFpbi9WMSNTUERfQUVTQ0FU
  :uri: http://www.s-cubed.dk/AE_Domain/V1#SPD_AESCAT
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmSponsorDomainVariable
  :label: Subcategory for Adverse Event
  :rule: ''
  :ordinal: 12
  :name: AESCAT
  :description: 'A further categorization of adverse event. Example: NEUROLOGIC.'
  :format: ''
  :ct_and_format: ''
  :compliance: http://www.assero.co.uk/CSN#f7d9d4e1-a00a-487e-89db-ebece910ba0d
  :ct_reference: []
  :based_on_class_variable: 
  :is_a: 
  :comment: ''
  :used: true
  :notes: ''
  :typed_as: 
  :based_on_ig_variable: http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AESCAT
- :id: aHR0cDovL3d3dy5zLWN1YmVkLmRrL0FFX0RvbWFpbi9WMSNTUERfQUVQUkVTUA==
  :uri: http://www.s-cubed.dk/AE_Domain/V1#SPD_AEPRESP
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmSponsorDomainVariable
  :label: Pre-Specified Adverse Event
  :rule: ''
  :ordinal: 13
  :name: AEPRESP
  :description: A value of 'Y' indicates that this adverse event was pre-specified
    on the CRF. Values are null for spontaneously reported events (i.e., those collected
    as free-text verbatim terms)
  :format: ''
  :ct_and_format: "(NY)"
  :compliance: http://www.assero.co.uk/CSN#f7d9d4e1-a00a-487e-89db-ebece910ba0d
  :ct_reference:
  - :id: aHR0cDovL3d3dy5jZGlzYy5vcmcvU0RUTV9JR19BRS9WMSNJR0RfQUVQUkVTUF9UTUMx
    :uri: http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AEPRESP_TMC1
    :rdf_type: http://www.assero.co.uk/BusinessOperational#TMcReference
    :label: NY
    :enabled: true
    :optional: false
    :ordinal: 1
    :reference: http://www.cdisc.org/C66742/V4#C66742
    :context: http://www.cdisc.org/CT/V13#TH
  :based_on_class_variable: 
  :is_a: 
  :comment: ''
  :used: true
  :notes: ''
  :typed_as: 
  :based_on_ig_variable: http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AEPRESP
- :id: aHR0cDovL3d3dy5zLWN1YmVkLmRrL0FFX0RvbWFpbi9WMSNTUERfQUVCT0RTWVM=
  :uri: http://www.s-cubed.dk/AE_Domain/V1#SPD_AEBODSYS
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmSponsorDomainVariable
  :label: Body System or Organ Class
  :rule: ''
  :ordinal: 14
  :name: AEBODSYS
  :description: Dictionary derived. Body system or organ class used by the sponsor
    from the coding dictionary (e.g., MedDRA). When using a multi-axial dictionary
    such as MedDRA, this should contain the SOC used for the sponsor's analyses and
    summary tables which may not necessarily be the primary SOC.
  :format: ''
  :ct_and_format: ''
  :compliance: http://www.assero.co.uk/CSN#046f6c24-9eaf-4f60-8390-f36328c82ec4
  :ct_reference: []
  :based_on_class_variable: 
  :is_a: 
  :comment: ''
  :used: true
  :notes: ''
  :typed_as: 
  :based_on_ig_variable: http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AEBODSYS
- :id: aHR0cDovL3d3dy5zLWN1YmVkLmRrL0FFX0RvbWFpbi9WMSNTUERfQUVMT0M=
  :uri: http://www.s-cubed.dk/AE_Domain/V1#SPD_AELOC
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmSponsorDomainVariable
  :label: Location of Event
  :rule: ''
  :ordinal: 15
  :name: AELOC
  :description: Describes anatomical location relevant for the event (e.g., LEFT ARM
    for skin rash).
  :format: ''
  :ct_and_format: "(LOC)"
  :compliance: http://www.assero.co.uk/CSN#f7d9d4e1-a00a-487e-89db-ebece910ba0d
  :ct_reference:
  - :id: aHR0cDovL3d3dy5jZGlzYy5vcmcvU0RUTV9JR19BRS9WMSNJR0RfQUVMT0NfVE1DMQ==
    :uri: http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AELOC_TMC1
    :rdf_type: http://www.assero.co.uk/BusinessOperational#TMcReference
    :label: LOC
    :enabled: true
    :optional: false
    :ordinal: 1
    :reference: http://www.cdisc.org/C74456/V8#C74456
    :context: http://www.cdisc.org/CT/V13#TH
  :based_on_class_variable: 
  :is_a: 
  :comment: ''
  :used: true
  :notes: ''
  :typed_as: 
  :based_on_ig_variable: http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AELOC
- :id: aHR0cDovL3d3dy5zLWN1YmVkLmRrL0FFX0RvbWFpbi9WMSNTUERfQUVTRVY=
  :uri: http://www.s-cubed.dk/AE_Domain/V1#SPD_AESEV
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmSponsorDomainVariable
  :label: Severity/Intensity
  :rule: ''
  :ordinal: 16
  :name: AESEV
  :description: 'The severity or intensity of the event. Examples: MILD, MODERATE,
    SEVERE.'
  :format: ''
  :ct_and_format: "(AESEV)"
  :compliance: http://www.assero.co.uk/CSN#f7d9d4e1-a00a-487e-89db-ebece910ba0d
  :ct_reference:
  - :id: aHR0cDovL3d3dy5jZGlzYy5vcmcvU0RUTV9JR19BRS9WMSNJR0RfQUVTRVZfVE1DMQ==
    :uri: http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AESEV_TMC1
    :rdf_type: http://www.assero.co.uk/BusinessOperational#TMcReference
    :label: AESEV
    :enabled: true
    :optional: false
    :ordinal: 1
    :reference: http://www.cdisc.org/C66769/V4#C66769
    :context: http://www.cdisc.org/CT/V13#TH
  :based_on_class_variable: 
  :is_a: 
  :comment: ''
  :used: true
  :notes: ''
  :typed_as: 
  :based_on_ig_variable: http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AESEV
- :id: aHR0cDovL3d3dy5zLWN1YmVkLmRrL0FFX0RvbWFpbi9WMSNTUERfQUVTRVI=
  :uri: http://www.s-cubed.dk/AE_Domain/V1#SPD_AESER
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmSponsorDomainVariable
  :label: Serious Event
  :rule: ''
  :ordinal: 17
  :name: AESER
  :description: Is this a serious event?
  :format: ''
  :ct_and_format: "(NY)"
  :compliance: http://www.assero.co.uk/CSN#046f6c24-9eaf-4f60-8390-f36328c82ec4
  :ct_reference:
  - :id: aHR0cDovL3d3dy5jZGlzYy5vcmcvU0RUTV9JR19BRS9WMSNJR0RfQUVTRVJfVE1DMQ==
    :uri: http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AESER_TMC1
    :rdf_type: http://www.assero.co.uk/BusinessOperational#TMcReference
    :label: NY
    :enabled: true
    :optional: false
    :ordinal: 1
    :reference: http://www.cdisc.org/C66742/V4#C66742
    :context: http://www.cdisc.org/CT/V13#TH
  :based_on_class_variable: 
  :is_a: 
  :comment: ''
  :used: true
  :notes: ''
  :typed_as: 
  :based_on_ig_variable: http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AESER
- :id: aHR0cDovL3d3dy5zLWN1YmVkLmRrL0FFX0RvbWFpbi9WMSNTUERfQUVBQ04=
  :uri: http://www.s-cubed.dk/AE_Domain/V1#SPD_AEACN
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmSponsorDomainVariable
  :label: Action Taken with Study Treatment
  :rule: ''
  :ordinal: 18
  :name: AEACN
  :description: 'Describes changes to the study treatment as a result of the event.
    AEACN is specifically for the relationship to study treatment. AEACNOTH is for
    actions unrelated to dose adjustments of study treatment. Examples of AEACN values
    include ICH E2B values: DRUG WITHDRAWN, DOSE REDUCED, DOSE INCREASED, DOSE NOT
    CHANGED, UNKNOWN or NOT APPLICABLE'
  :format: ''
  :ct_and_format: "(ACN)"
  :compliance: http://www.assero.co.uk/CSN#046f6c24-9eaf-4f60-8390-f36328c82ec4
  :ct_reference:
  - :id: aHR0cDovL3d3dy5jZGlzYy5vcmcvU0RUTV9JR19BRS9WMSNJR0RfQUVBQ05fVE1DMQ==
    :uri: http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AEACN_TMC1
    :rdf_type: http://www.assero.co.uk/BusinessOperational#TMcReference
    :label: ACN
    :enabled: true
    :optional: false
    :ordinal: 1
    :reference: http://www.cdisc.org/C66767/V4#C66767
    :context: http://www.cdisc.org/CT/V13#TH
  :based_on_class_variable: 
  :is_a: 
  :comment: ''
  :used: true
  :notes: ''
  :typed_as: 
  :based_on_ig_variable: http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AEACN
- :id: aHR0cDovL3d3dy5zLWN1YmVkLmRrL0FFX0RvbWFpbi9WMSNTUERfQUVBQ05PVEg=
  :uri: http://www.s-cubed.dk/AE_Domain/V1#SPD_AEACNOTH
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmSponsorDomainVariable
  :label: Other Action Taken
  :rule: ''
  :ordinal: 19
  :name: AEACNOTH
  :description: 'Describes other actions taken as a result of the event that are unrelated
    to dose adjustments of study treatment. Usually reported as free text. Example:
    ''TREATMENT UNBLINDED. PRIMARY CARE PHYSICIAN NOTIFIED.'''
  :format: ''
  :ct_and_format: ''
  :compliance: http://www.assero.co.uk/CSN#f7d9d4e1-a00a-487e-89db-ebece910ba0d
  :ct_reference: []
  :based_on_class_variable: 
  :is_a: 
  :comment: ''
  :used: true
  :notes: ''
  :typed_as: 
  :based_on_ig_variable: http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AEACNOTH
- :id: aHR0cDovL3d3dy5zLWN1YmVkLmRrL0FFX0RvbWFpbi9WMSNTUERfQUVSRUw=
  :uri: http://www.s-cubed.dk/AE_Domain/V1#SPD_AEREL
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmSponsorDomainVariable
  :label: Causality
  :rule: ''
  :ordinal: 20
  :name: AEREL
  :description: Records the investigator's opinion as to the causality of the event
    to the treatment. ICH E2A and E2B examples include NOT RELATED, UNLIKELY RELATED,
    POSSIBLY RELATED, RELATED. Controlled Terminology may be defined in the future.
    Check with regulatory authority for population of this variable
  :format: ''
  :ct_and_format: ''
  :compliance: http://www.assero.co.uk/CSN#046f6c24-9eaf-4f60-8390-f36328c82ec4
  :ct_reference: []
  :based_on_class_variable: 
  :is_a: 
  :comment: ''
  :used: true
  :notes: ''
  :typed_as: 
  :based_on_ig_variable: http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AEREL
- :id: aHR0cDovL3d3dy5zLWN1YmVkLmRrL0FFX0RvbWFpbi9WMSNTUERfQUVSRUxOU1Q=
  :uri: http://www.s-cubed.dk/AE_Domain/V1#SPD_AERELNST
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmSponsorDomainVariable
  :label: Relationship to Non-Study Treatment
  :rule: ''
  :ordinal: 21
  :name: AERELNST
  :description: 'Records the investigator''s opinion as to whether the event may have
    been due to a treatment other than study drug. May be reported as free text. Example:
    ''MORE LIKELY RELATED TO ASPIRIN USE.''.'
  :format: ''
  :ct_and_format: ''
  :compliance: http://www.assero.co.uk/CSN#f7d9d4e1-a00a-487e-89db-ebece910ba0d
  :ct_reference: []
  :based_on_class_variable: 
  :is_a: 
  :comment: ''
  :used: true
  :notes: ''
  :typed_as: 
  :based_on_ig_variable: http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AERELNST
- :id: aHR0cDovL3d3dy5zLWN1YmVkLmRrL0FFX0RvbWFpbi9WMSNTUERfQUVQQVRU
  :uri: http://www.s-cubed.dk/AE_Domain/V1#SPD_AEPATT
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmSponsorDomainVariable
  :label: Pattern of Adverse Event
  :rule: ''
  :ordinal: 22
  :name: AEPATT
  :description: 'Used to indicate the pattern of the event over time. Examples: INTERMITTENT,
    CONTINUOUS, SINGLE EVENT.'
  :format: ''
  :ct_and_format: ''
  :compliance: http://www.assero.co.uk/CSN#f7d9d4e1-a00a-487e-89db-ebece910ba0d
  :ct_reference: []
  :based_on_class_variable: 
  :is_a: 
  :comment: ''
  :used: true
  :notes: ''
  :typed_as: 
  :based_on_ig_variable: http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AEPATT
- :id: aHR0cDovL3d3dy5zLWN1YmVkLmRrL0FFX0RvbWFpbi9WMSNTUERfQUVPVVQ=
  :uri: http://www.s-cubed.dk/AE_Domain/V1#SPD_AEOUT
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmSponsorDomainVariable
  :label: Outcome of Adverse Event
  :rule: ''
  :ordinal: 23
  :name: AEOUT
  :description: Description of the outcome of an event.
  :format: ''
  :ct_and_format: "(OUT)"
  :compliance: http://www.assero.co.uk/CSN#f7d9d4e1-a00a-487e-89db-ebece910ba0d
  :ct_reference:
  - :id: aHR0cDovL3d3dy5jZGlzYy5vcmcvU0RUTV9JR19BRS9WMSNJR0RfQUVPVVRfVE1DMQ==
    :uri: http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AEOUT_TMC1
    :rdf_type: http://www.assero.co.uk/BusinessOperational#TMcReference
    :label: OUT
    :enabled: true
    :optional: false
    :ordinal: 1
    :reference: http://www.cdisc.org/C66768/V4#C66768
    :context: http://www.cdisc.org/CT/V13#TH
  :based_on_class_variable: 
  :is_a: 
  :comment: ''
  :used: true
  :notes: ''
  :typed_as: 
  :based_on_ig_variable: http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AEOUT
- :id: aHR0cDovL3d3dy5zLWN1YmVkLmRrL0FFX0RvbWFpbi9WMSNTUERfQUVTQ0FO
  :uri: http://www.s-cubed.dk/AE_Domain/V1#SPD_AESCAN
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmSponsorDomainVariable
  :label: Involves Cancer
  :rule: ''
  :ordinal: 24
  :name: AESCAN
  :description: Was the serious event associated with the development of cancer?
  :format: ''
  :ct_and_format: "(NY)"
  :compliance: http://www.assero.co.uk/CSN#f7d9d4e1-a00a-487e-89db-ebece910ba0d
  :ct_reference:
  - :id: aHR0cDovL3d3dy5jZGlzYy5vcmcvU0RUTV9JR19BRS9WMSNJR0RfQUVTQ0FOX1RNQzE=
    :uri: http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AESCAN_TMC1
    :rdf_type: http://www.assero.co.uk/BusinessOperational#TMcReference
    :label: NY
    :enabled: true
    :optional: false
    :ordinal: 1
    :reference: http://www.cdisc.org/C66742/V4#C66742
    :context: http://www.cdisc.org/CT/V13#TH
  :based_on_class_variable: 
  :is_a: 
  :comment: ''
  :used: true
  :notes: ''
  :typed_as: 
  :based_on_ig_variable: http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AESCAN
- :id: aHR0cDovL3d3dy5zLWN1YmVkLmRrL0FFX0RvbWFpbi9WMSNTUERfQUVTQ09ORw==
  :uri: http://www.s-cubed.dk/AE_Domain/V1#SPD_AESCONG
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmSponsorDomainVariable
  :label: Congenital Anomaly or Birth Defect
  :rule: ''
  :ordinal: 25
  :name: AESCONG
  :description: Was the serious event associated with congenital anomaly or birth
    defect?
  :format: ''
  :ct_and_format: "(NY)"
  :compliance: http://www.assero.co.uk/CSN#f7d9d4e1-a00a-487e-89db-ebece910ba0d
  :ct_reference:
  - :id: aHR0cDovL3d3dy5jZGlzYy5vcmcvU0RUTV9JR19BRS9WMSNJR0RfQUVTQ09OR19UTUMx
    :uri: http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AESCONG_TMC1
    :rdf_type: http://www.assero.co.uk/BusinessOperational#TMcReference
    :label: NY
    :enabled: true
    :optional: false
    :ordinal: 1
    :reference: http://www.cdisc.org/C66742/V4#C66742
    :context: http://www.cdisc.org/CT/V13#TH
  :based_on_class_variable: 
  :is_a: 
  :comment: ''
  :used: true
  :notes: ''
  :typed_as: 
  :based_on_ig_variable: http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AESCONG
- :id: aHR0cDovL3d3dy5zLWN1YmVkLmRrL0FFX0RvbWFpbi9WMSNTUERfQUVTRElTQUI=
  :uri: http://www.s-cubed.dk/AE_Domain/V1#SPD_AESDISAB
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmSponsorDomainVariable
  :label: Persist or Signif Disability/Incapacity
  :rule: ''
  :ordinal: 26
  :name: AESDISAB
  :description: Did the serious event result in persistent or significant disability/incapacity?
  :format: ''
  :ct_and_format: "(NY)"
  :compliance: http://www.assero.co.uk/CSN#f7d9d4e1-a00a-487e-89db-ebece910ba0d
  :ct_reference:
  - :id: aHR0cDovL3d3dy5jZGlzYy5vcmcvU0RUTV9JR19BRS9WMSNJR0RfQUVTRElTQUJfVE1DMQ==
    :uri: http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AESDISAB_TMC1
    :rdf_type: http://www.assero.co.uk/BusinessOperational#TMcReference
    :label: NY
    :enabled: true
    :optional: false
    :ordinal: 1
    :reference: http://www.cdisc.org/C66742/V4#C66742
    :context: http://www.cdisc.org/CT/V13#TH
  :based_on_class_variable: 
  :is_a: 
  :comment: ''
  :used: true
  :notes: ''
  :typed_as: 
  :based_on_ig_variable: http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AESDISAB
- :id: aHR0cDovL3d3dy5zLWN1YmVkLmRrL0FFX0RvbWFpbi9WMSNTUERfQUVTRFRI
  :uri: http://www.s-cubed.dk/AE_Domain/V1#SPD_AESDTH
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmSponsorDomainVariable
  :label: Results in Death
  :rule: ''
  :ordinal: 27
  :name: AESDTH
  :description: Did the serious event result in death?
  :format: ''
  :ct_and_format: "(NY)"
  :compliance: http://www.assero.co.uk/CSN#f7d9d4e1-a00a-487e-89db-ebece910ba0d
  :ct_reference:
  - :id: aHR0cDovL3d3dy5jZGlzYy5vcmcvU0RUTV9JR19BRS9WMSNJR0RfQUVTRFRIX1RNQzE=
    :uri: http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AESDTH_TMC1
    :rdf_type: http://www.assero.co.uk/BusinessOperational#TMcReference
    :label: NY
    :enabled: true
    :optional: false
    :ordinal: 1
    :reference: http://www.cdisc.org/C66742/V4#C66742
    :context: http://www.cdisc.org/CT/V13#TH
  :based_on_class_variable: 
  :is_a: 
  :comment: ''
  :used: true
  :notes: ''
  :typed_as: 
  :based_on_ig_variable: http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AESDTH
- :id: aHR0cDovL3d3dy5zLWN1YmVkLmRrL0FFX0RvbWFpbi9WMSNTUERfQUVTSE9TUA==
  :uri: http://www.s-cubed.dk/AE_Domain/V1#SPD_AESHOSP
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmSponsorDomainVariable
  :label: Requires or Prolongs Hospitalization
  :rule: ''
  :ordinal: 28
  :name: AESHOSP
  :description: Did the serious event require or prolong hospitalization?
  :format: ''
  :ct_and_format: "(NY)"
  :compliance: http://www.assero.co.uk/CSN#f7d9d4e1-a00a-487e-89db-ebece910ba0d
  :ct_reference:
  - :id: aHR0cDovL3d3dy5jZGlzYy5vcmcvU0RUTV9JR19BRS9WMSNJR0RfQUVTSE9TUF9UTUMx
    :uri: http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AESHOSP_TMC1
    :rdf_type: http://www.assero.co.uk/BusinessOperational#TMcReference
    :label: NY
    :enabled: true
    :optional: false
    :ordinal: 1
    :reference: http://www.cdisc.org/C66742/V4#C66742
    :context: http://www.cdisc.org/CT/V13#TH
  :based_on_class_variable: 
  :is_a: 
  :comment: ''
  :used: true
  :notes: ''
  :typed_as: 
  :based_on_ig_variable: http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AESHOSP
- :id: aHR0cDovL3d3dy5zLWN1YmVkLmRrL0FFX0RvbWFpbi9WMSNTUERfQUVTTElGRQ==
  :uri: http://www.s-cubed.dk/AE_Domain/V1#SPD_AESLIFE
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmSponsorDomainVariable
  :label: Is Life Threatening
  :rule: ''
  :ordinal: 29
  :name: AESLIFE
  :description: Was the serious event life threatening?
  :format: ''
  :ct_and_format: "(NY)"
  :compliance: http://www.assero.co.uk/CSN#f7d9d4e1-a00a-487e-89db-ebece910ba0d
  :ct_reference:
  - :id: aHR0cDovL3d3dy5jZGlzYy5vcmcvU0RUTV9JR19BRS9WMSNJR0RfQUVTTElGRV9UTUMx
    :uri: http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AESLIFE_TMC1
    :rdf_type: http://www.assero.co.uk/BusinessOperational#TMcReference
    :label: NY
    :enabled: true
    :optional: false
    :ordinal: 1
    :reference: http://www.cdisc.org/C66742/V4#C66742
    :context: http://www.cdisc.org/CT/V13#TH
  :based_on_class_variable: 
  :is_a: 
  :comment: ''
  :used: true
  :notes: ''
  :typed_as: 
  :based_on_ig_variable: http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AESLIFE
- :id: aHR0cDovL3d3dy5zLWN1YmVkLmRrL0FFX0RvbWFpbi9WMSNTUERfQUVTT0Q=
  :uri: http://www.s-cubed.dk/AE_Domain/V1#SPD_AESOD
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmSponsorDomainVariable
  :label: Occurred with Overdose
  :rule: ''
  :ordinal: 30
  :name: AESOD
  :description: Did the serious event occur with an overdose?
  :format: ''
  :ct_and_format: "(NY)"
  :compliance: http://www.assero.co.uk/CSN#f7d9d4e1-a00a-487e-89db-ebece910ba0d
  :ct_reference:
  - :id: aHR0cDovL3d3dy5jZGlzYy5vcmcvU0RUTV9JR19BRS9WMSNJR0RfQUVTT0RfVE1DMQ==
    :uri: http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AESOD_TMC1
    :rdf_type: http://www.assero.co.uk/BusinessOperational#TMcReference
    :label: NY
    :enabled: true
    :optional: false
    :ordinal: 1
    :reference: http://www.cdisc.org/C66742/V4#C66742
    :context: http://www.cdisc.org/CT/V13#TH
  :based_on_class_variable: 
  :is_a: 
  :comment: ''
  :used: true
  :notes: ''
  :typed_as: 
  :based_on_ig_variable: http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AESOD
- :id: aHR0cDovL3d3dy5zLWN1YmVkLmRrL0FFX0RvbWFpbi9WMSNTUERfQUVTTUlF
  :uri: http://www.s-cubed.dk/AE_Domain/V1#SPD_AESMIE
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmSponsorDomainVariable
  :label: Other Medically Important Serious Event
  :rule: ''
  :ordinal: 31
  :name: AESMIE
  :description: Do additional categories for seriousness apply?
  :format: ''
  :ct_and_format: "(NY)"
  :compliance: http://www.assero.co.uk/CSN#f7d9d4e1-a00a-487e-89db-ebece910ba0d
  :ct_reference:
  - :id: aHR0cDovL3d3dy5jZGlzYy5vcmcvU0RUTV9JR19BRS9WMSNJR0RfQUVTTUlFX1RNQzE=
    :uri: http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AESMIE_TMC1
    :rdf_type: http://www.assero.co.uk/BusinessOperational#TMcReference
    :label: NY
    :enabled: true
    :optional: false
    :ordinal: 1
    :reference: http://www.cdisc.org/C66742/V4#C66742
    :context: http://www.cdisc.org/CT/V13#TH
  :based_on_class_variable: 
  :is_a: 
  :comment: ''
  :used: true
  :notes: ''
  :typed_as: 
  :based_on_ig_variable: http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AESMIE
- :id: aHR0cDovL3d3dy5zLWN1YmVkLmRrL0FFX0RvbWFpbi9WMSNTUERfQUVDT05UUlQ=
  :uri: http://www.s-cubed.dk/AE_Domain/V1#SPD_AECONTRT
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmSponsorDomainVariable
  :label: Concomitant or Additional Trtmnt Given
  :rule: ''
  :ordinal: 32
  :name: AECONTRT
  :description: Was another treatment given because of the occurrence of the event?
  :format: ''
  :ct_and_format: "(NY)"
  :compliance: http://www.assero.co.uk/CSN#f7d9d4e1-a00a-487e-89db-ebece910ba0d
  :ct_reference:
  - :id: aHR0cDovL3d3dy5jZGlzYy5vcmcvU0RUTV9JR19BRS9WMSNJR0RfQUVDT05UUlRfVE1DMQ==
    :uri: http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AECONTRT_TMC1
    :rdf_type: http://www.assero.co.uk/BusinessOperational#TMcReference
    :label: NY
    :enabled: true
    :optional: false
    :ordinal: 1
    :reference: http://www.cdisc.org/C66742/V4#C66742
    :context: http://www.cdisc.org/CT/V13#TH
  :based_on_class_variable: 
  :is_a: 
  :comment: ''
  :used: true
  :notes: ''
  :typed_as: 
  :based_on_ig_variable: http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AECONTRT
- :id: aHR0cDovL3d3dy5zLWN1YmVkLmRrL0FFX0RvbWFpbi9WMSNTUERfQUVUT1hHUg==
  :uri: http://www.s-cubed.dk/AE_Domain/V1#SPD_AETOXGR
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmSponsorDomainVariable
  :label: Standard Toxicity Grade
  :rule: ''
  :ordinal: 33
  :name: AETOXGR
  :description: Toxicity grade according to a standard toxicity scale such as Common
    Terminology Criteria for Adverse Events v3.0 (CTCAE). Sponsor should specify name
    of the scale and version used in the metadata (see 6.2.1.1, Assumption 6c). If
    value is from a numeric scale, represent only the number (e.g., '2' and not 'Grade
    2').
  :format: ''
  :ct_and_format: ''
  :compliance: http://www.assero.co.uk/CSN#f7d9d4e1-a00a-487e-89db-ebece910ba0d
  :ct_reference: []
  :based_on_class_variable: 
  :is_a: 
  :comment: ''
  :used: true
  :notes: ''
  :typed_as: 
  :based_on_ig_variable: http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AETOXGR
- :id: aHR0cDovL3d3dy5zLWN1YmVkLmRrL0FFX0RvbWFpbi9WMSNTUERfQUVTVERUQw==
  :uri: http://www.s-cubed.dk/AE_Domain/V1#SPD_AESTDTC
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmSponsorDomainVariable
  :label: Start Date/Time of Adverse Event
  :rule: ''
  :ordinal: 34
  :name: AESTDTC
  :description: ''
  :format: ISO 8601
  :ct_and_format: ISO 8601
  :compliance: http://www.assero.co.uk/CSN#046f6c24-9eaf-4f60-8390-f36328c82ec4
  :ct_reference: []
  :based_on_class_variable: 
  :is_a: 
  :comment: ''
  :used: true
  :notes: ''
  :typed_as: 
  :based_on_ig_variable: http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AESTDTC
- :id: aHR0cDovL3d3dy5zLWN1YmVkLmRrL0FFX0RvbWFpbi9WMSNTUERfQUVFTkRUQw==
  :uri: http://www.s-cubed.dk/AE_Domain/V1#SPD_AEENDTC
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmSponsorDomainVariable
  :label: End Date/Time of Adverse Event
  :rule: ''
  :ordinal: 35
  :name: AEENDTC
  :description: ''
  :format: ISO 8601
  :ct_and_format: ISO 8601
  :compliance: http://www.assero.co.uk/CSN#046f6c24-9eaf-4f60-8390-f36328c82ec4
  :ct_reference: []
  :based_on_class_variable: 
  :is_a: 
  :comment: ''
  :used: true
  :notes: ''
  :typed_as: 
  :based_on_ig_variable: http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AEENDTC
- :id: aHR0cDovL3d3dy5zLWN1YmVkLmRrL0FFX0RvbWFpbi9WMSNTUERfQUVTVERZ
  :uri: http://www.s-cubed.dk/AE_Domain/V1#SPD_AESTDY
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmSponsorDomainVariable
  :label: Study Day of Start of Adverse Event
  :rule: ''
  :ordinal: 36
  :name: AESTDY
  :description: Study day of start of adverse event relative to the sponsor-defined
    RFSTDTC.
  :format: ''
  :ct_and_format: ''
  :compliance: http://www.assero.co.uk/CSN#f7d9d4e1-a00a-487e-89db-ebece910ba0d
  :ct_reference: []
  :based_on_class_variable: 
  :is_a: 
  :comment: ''
  :used: true
  :notes: ''
  :typed_as: 
  :based_on_ig_variable: http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AESTDY
- :id: aHR0cDovL3d3dy5zLWN1YmVkLmRrL0FFX0RvbWFpbi9WMSNTUERfQUVFTkRZ
  :uri: http://www.s-cubed.dk/AE_Domain/V1#SPD_AEENDY
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmSponsorDomainVariable
  :label: Study Day of End of Adverse Event
  :rule: ''
  :ordinal: 37
  :name: AEENDY
  :description: Study day of end of event relative to the sponsor-defined RFSTDTC.
  :format: ''
  :ct_and_format: ''
  :compliance: http://www.assero.co.uk/CSN#f7d9d4e1-a00a-487e-89db-ebece910ba0d
  :ct_reference: []
  :based_on_class_variable: 
  :is_a: 
  :comment: ''
  :used: true
  :notes: ''
  :typed_as: 
  :based_on_ig_variable: http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AEENDY
- :id: aHR0cDovL3d3dy5zLWN1YmVkLmRrL0FFX0RvbWFpbi9WMSNTUERfQUVEVVI=
  :uri: http://www.s-cubed.dk/AE_Domain/V1#SPD_AEDUR
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmSponsorDomainVariable
  :label: Duration of Adverse Event
  :rule: ''
  :ordinal: 38
  :name: AEDUR
  :description: 'Collected duration and unit of an adverse event. Used only if collected
    on the CRF and not derived from start and end date/times. Example: P1DT2H (for
    1 day, 2 hours).'
  :format: ISO 8601
  :ct_and_format: ISO 8601
  :compliance: http://www.assero.co.uk/CSN#f7d9d4e1-a00a-487e-89db-ebece910ba0d
  :ct_reference: []
  :based_on_class_variable: 
  :is_a: 
  :comment: ''
  :used: true
  :notes: ''
  :typed_as: 
  :based_on_ig_variable: http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AEDUR
- :id: aHR0cDovL3d3dy5zLWN1YmVkLmRrL0FFX0RvbWFpbi9WMSNTUERfQUVFTlJG
  :uri: http://www.s-cubed.dk/AE_Domain/V1#SPD_AEENRF
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmSponsorDomainVariable
  :label: End Relative to Reference Period
  :rule: ''
  :ordinal: 39
  :name: AEENRF
  :description: Describes the end of the event relative to the sponsor-defined reference
    period. The sponsor-defined reference period is a continuous period of time defined
    by a discrete starting point (RFSTDTC) and a discrete ending point (RFENDTC) of
    the trial.
  :format: ''
  :ct_and_format: "(STENRF)"
  :compliance: http://www.assero.co.uk/CSN#f7d9d4e1-a00a-487e-89db-ebece910ba0d
  :ct_reference:
  - :id: aHR0cDovL3d3dy5jZGlzYy5vcmcvU0RUTV9JR19BRS9WMSNJR0RfQUVFTlJGX1RNQzE=
    :uri: http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AEENRF_TMC1
    :rdf_type: http://www.assero.co.uk/BusinessOperational#TMcReference
    :label: STENRF
    :enabled: true
    :optional: false
    :ordinal: 1
    :reference: http://www.cdisc.org/C66728/V4#C66728
    :context: http://www.cdisc.org/CT/V13#TH
  :based_on_class_variable: 
  :is_a: 
  :comment: ''
  :used: true
  :notes: ''
  :typed_as: 
  :based_on_ig_variable: http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AEENRF
- :id: aHR0cDovL3d3dy5zLWN1YmVkLmRrL0FFX0RvbWFpbi9WMSNTUERfQUVFTlJUUFQ=
  :uri: http://www.s-cubed.dk/AE_Domain/V1#SPD_AEENRTPT
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmSponsorDomainVariable
  :label: End Relative to Reference Time Point
  :rule: ''
  :ordinal: 40
  :name: AEENRTPT
  :description: Identifies the end of the event as being before or after the reference
    time point defined by variable AEENTPT.
  :format: BEFORE, AFTER, COINCIDENT, ONGOING, U
  :ct_and_format: BEFORE, AFTER, COINCIDENT, ONGOING, U
  :compliance: http://www.assero.co.uk/CSN#f7d9d4e1-a00a-487e-89db-ebece910ba0d
  :ct_reference: []
  :based_on_class_variable: 
  :is_a: 
  :comment: ''
  :used: true
  :notes: ''
  :typed_as: 
  :based_on_ig_variable: http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AEENRTPT
- :id: aHR0cDovL3d3dy5zLWN1YmVkLmRrL0FFX0RvbWFpbi9WMSNTUERfQUVFTlRQVA==
  :uri: http://www.s-cubed.dk/AE_Domain/V1#SPD_AEENTPT
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmSponsorDomainVariable
  :label: End Reference Time Point
  :rule: ''
  :ordinal: 41
  :name: AEENTPT
  :description: 'Description of date/time in ISO 8601 character format of the reference
    point referred to by AEENRTPT. Examples: ''2003-12-25'' or ''VISIT 2''.'
  :format: ''
  :ct_and_format: ''
  :compliance: http://www.assero.co.uk/CSN#f7d9d4e1-a00a-487e-89db-ebece910ba0d
  :ct_reference: []
  :based_on_class_variable: 
  :is_a: 
  :comment: ''
  :used: true
  :notes: ''
  :typed_as: 
  :based_on_ig_variable: http://www.cdisc.org/SDTM_IG_AE/V1#IGD_AEENTPT
- :id: aHR0cDovL3d3dy5zLWN1YmVkLmRrL0FFX0RvbWFpbi9WMSNTUERfQUVORVdWQVI=
  :uri: http://www.s-cubed.dk/AE_Domain/V1#SPD_AENEWVAR
  :rdf_type: http://www.assero.co.uk/Tabulation#SdtmSponsorDomainVariable
  :label: ''
  :rule: ''
  :ordinal: 42
  :name: AENEWVAR
  :description: ''
  :format: ''
  :ct_and_format: ''
  :compliance: 
  :ct_reference: []
  :based_on_class_variable: 
  :is_a: 
  :comment: ''
  :used: true
  :notes: ''
  :typed_as: 
  :based_on_ig_variable: 
:prefix: AE
:structure: One record per adverse event per subject
:has_biomedical_concept: []
:based_on_class: http://www.cdisc.org/SDTM_MODEL_EVENTS/V1#CL
